FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof: (I) where R1, R2 and R3, which are identical or different, denote H, lower alkyl; R4, R5, R6, R7 and R8, which are identical or different, denote H, lower alkyl, halogen, nitro, -X-OR0, -X-NR10R11, -X-NR0C(O)R10, -X-O-halogen lower alkyl, -X-O-X-phenyl; or R6 and R7 are combined to form -O-lower alkylene-O-; R, which is identical or different, denotes H, lower alkyl; R10, R11, which are identical or different, denote H, lower alkyl; X, which is identical or different, denotes a bond, lower alkylene.
EFFECT: compounds exhibit type 5 17βHSD inhibiting activity, which enables their use in producing a pharmaceutical composition and in a method of inhibiting type 5 17βHSD.
15 cl, 11 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
4-AMINO-IMIDAZOQUINOLINE DERIVATIVES, USEFUL IN TREATING DISEASES MEDIATED BY TLR7 AND/OR TLR8 AGONISTS | 2015 |
|
RU2698902C2 |
SPIROCHROMANONE DERIVATIVES AS ACETYL COENZYME A CARBOXYLASE (ACC) INHIBITORS | 2006 |
|
RU2422446C2 |
AMID DERIVATIVE | 2004 |
|
RU2336273C2 |
PYRIDYL NONAROMATIC NITROGEN-CONTAINING HETEROCYCLO-1-CARBOXYLATE DERIVATIVE | 2006 |
|
RU2408581C2 |
METHOD FOR PREDICTING THE THERAPEUTIC EFFECT OF AN LSD 1INHIBITOR BASED ON THE INSM1 EXPRESSION | 2018 |
|
RU2789449C2 |
PYRIDYL NONAROMATIC NITROGEN-CONTAINING HETEROCYCLO-1-CARBOXYLATE DERIVATIVE | 2006 |
|
RU2408580C2 |
DIAMINOHETEROCYCLIC CARBOXAMIDE COMPOUND | 2010 |
|
RU2526253C2 |
NOVEL COMPOUNDS AND FASN INHIBITION COMPOSITIONS | 2014 |
|
RU2737434C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2008 |
|
RU2512682C2 |
AMINOPYRAZOLE DERIVATIVE | 2010 |
|
RU2580543C9 |
Authors
Dates
2012-12-20—Published
2008-08-28—Filed